Silo Pharma(US:SILO) Globenewswireยท2025-10-08 12:45Core Insights - Silo Pharma has initiated its first Bitcoin purchase as part of a broader crypto reserve strategy aimed at multi-chain asset growth [1][2] - The CEO of Silo Pharma expressed confidence in Bitcoin as a store of value and a hedge against market volatility, highlighting the company's commitment to digital asset investments [2] - Silo Pharma's portfolio includes various therapeutic programs targeting conditions such as PTSD, fibromyalgia, and CNS diseases, indicating a diversified focus beyond cryptocurrency [3] Company Overview - Silo Pharma is a developmental-stage biopharmaceutical and cryptocurrency treasury company, focusing on underserved medical conditions [3] - The company collaborates with leading universities and laboratories for its research initiatives [3] Investment Strategy - The company has made multiple crypto investments, including Ethereum, RSC, and Solano tokens, and plans to continue expanding its digital asset portfolio [2] - The strategic approach reflects the company's belief in the growing adoption and value creation opportunities within the cryptocurrency market [2]